Literature DB >> 11283113

Relevance of reactivity in commercially available hepatitis C virus antibody assays.

S Polywka1, M Schröter, H H Feucht, B Zöllner, R Laufs.   

Abstract

Sera from 2,148 patients were tested with a third-generation microparticle enzyme immunoassay (MEIA), a confirmatory assay, and a reverse transcription-PCR. Overall, 85.6% of reactivities were confirmed, 13.2% were shown to be unspecifically reactive, and 1.2% were indeterminate. The rate of confirmed MEIA reactivities clearly depended on the strength of the reactivity.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11283113      PMCID： PMC87996          DOI： 10.1128/JCM.39.4.1665-1668.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Hepatitis C: advances in diagnosis.

Authors:  J B Gross; D H Persing
Journal:  Mayo Clin Proc       Date:  1995-03       Impact factor: 7.616

2.  Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays.

Authors:  M Schröter; B Zöllner; P Schäfer; R Laufs; H H Feucht
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Study on reliability of commercially available hepatitis C virus antibody tests.

Authors:  H H Feucht; B Zöllner; S Polywka; R Laufs
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

4.  Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients.

Authors:  D Bresters; H L Zaaijer; H T Cuypers; H W Reesink; I N Winkel; P J van Exel-Oehlers; A A van Drimmelen; P L Jansen; C L van der Poel; P N Lelie
Journal:  Transfusion       Date:  1993-08       Impact factor: 3.157

5.  Second generation hepatitis C virus assays: performance when testing African sera.

Authors:  J D Callahan; N T Constantine; P Kataaha; X Zhang; K C Hyams; J Bansal
Journal:  J Med Virol       Date:  1993-09       Impact factor: 2.327

6.  Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus.

Authors:  S K Dhaliwal; L E Prescott; B C Dow; F Davidson; H Brown; P L Yap; E A Follett; P Simmonds
Journal:  J Med Virol       Date:  1996-02       Impact factor: 2.327

7.  High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.

Authors:  J Bukh; P Wantzin; K Krogsgaard; F Knudsen; R H Purcell; R H Miller
Journal:  J Infect Dis       Date:  1993-12       Impact factor: 5.226

8.  Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay.

Authors:  S R Lee; C L Wood; M J Lane; B Francis; C Gust; C M Higgs; M J Nelles; A Polito; R DiNello; D Achord
Journal:  Transfusion       Date:  1995-10       Impact factor: 3.157

9.  Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus.

Authors:  M Damen; H L Zaaijer; H T Cuypers; H Vrielink; C L van der Poel; H W Reesink; P N Lelie
Journal:  Transfusion       Date:  1995-09       Impact factor: 3.157

10.  Hepatitis C virus antibody prevalence among human immunodeficiency virus-1-infected individuals: analysis with different test systems.

Authors:  C M Nübling; G von Wangenheim; S Staszewski; J Löwer
Journal:  J Med Virol       Date:  1994-09       Impact factor: 2.327
View more
  6 in total

1.  Hepatitis A, B, and C.

Authors:  R Gilson; M G Brook
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

2.  Laboratory diagnosis of viral hepatitis C: The Sultan Qaboos University Hospital experience.

Authors:  Said H S Al Dhahry; Jameel C Nograles; Situsekara M W W B Rajapakse; Fadhila S S Al Toqi; Geraldine Z Kaminski
Journal:  J Sci Res Med Sci       Date:  2003-08

3.  Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay.

Authors:  Mel Krajden; Rainer Ziermann; Asphani Khan; Annie Mak; Kimmy Leung; David Hendricks; Lorraine Comanor
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 4.  Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-11       Impact factor: 3.267

5.  Establishing a sample-to cut-off ratio for lab-diagnosis of hepatitis C virus in Indian context.

Authors:  Aseem K Tiwari; Prashant K Pandey; Avinash Negi; Ruchika Bagga; Ajay Shanker; Usha Baveja; Raina Vimarsh; Richa Bhargava; Ravi C Dara; Ganesh Rawat
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

6.  Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.

Authors:  Yeon Seok Seo; Eun Suk Jung; Jeong Han Kim; Young Kul Jung; Ji Hoon Kim; Hyonggin An; Hyung Joon Yim; Jong Eun Yeon; Kwan Soo Byun; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.